More back and forth as Abbvie talks up benefits of Shire acquisiton
By Nuala Moran
Staff Writer
Staff Writer
Wednesday, June 25, 2014
LONDON Is it the tax break or the products? Abbvie Inc. launched its public campaign to acquire Shire plc for $47 billion, promising synergies in the pipelines and the opportunity to use its marketing heft to expand Shire's rare diseases and attention deficit hyperactivity disorder (ADHD) franchises.
To continue reading subscribe now to Latest News
Learn More about Latest News
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.